Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

DOI: 10.1038/s41523-017-0033-7

Full-Text   Cite this paper   Add to My Lib

Abstract:

Baseline patient and tumor characteristic

Full-Text